Mutual Capital Partners Research
Investment Thesis
Mutual Capital Partners (MCP) is a Westlake, Ohio-based venture capital firm founded in 2005 that backs healthcare information technology and medical device companies. The firm's stated approach is to be more than a check-writer: "We help innovative healthcare startups reach their full potential. Our investment is more than just financial; we become partners and lend full support." MCP is one of the more established healthtech-focused funds in the Midwest, having deployed across four numbered funds (MCPF I through MCPF IV) over roughly two decades.
Sector Focus
MCP invests exclusively in two adjacent healthcare verticals:
- Healthcare IT / digital health platforms (patient engagement, benefits verification, care management, data analytics for provider and payer workflows)
- Medical devices (surgical instrumentation, implants, neurostimulation, diagnostics-adjacent hardware)
Representative portfolio splits roughly evenly between the two: software plays like Authenticx, Olio Health, Redi.Health, and eBlu Solutions sit alongside device companies like Cooler Heads, Checkpoint Surgical, OrthAlign, Catalyst OrthoScience, and Elevation Spine.
Stage Focus
MCP is a growth-stage investor, not a seed fund. Its published investment criteria require:
- Minimum $1M run-rate revenue
- 50%+ gross margins
- At least 5 reference customers with demonstrated renewal or expansion
- Equity capital needs of less than $10M
- Strong existing management team
This profile corresponds to companies that have already found initial product-market fit and are raising expansion or Series A-equivalent capital to scale commercialization, rather than pre-revenue or concept-stage companies.
Check Size
MCP's own criteria cap target equity needs at "less than $10 million," implying MCP's checks (often as part of a syndicate) run up to roughly that ceiling per round. In the Cooler Heads Series A ($11M, July 2025), MCP was the lead investor in a round that included seven other participants (SHD Partners, Crescent Ridge VC, Cal Innovation Fund, NuFund, Robin Hood Ventures, Golden Seeds, HIP VC, plus an unnamed strategic), suggesting MCP's own check was a meaningful but not majority piece of an $11M round.
Lead Tendency
MCP leads rounds when the opportunity fits its thesis tightly — it led the Cooler Heads Series A outright. Historical exits (Cleveland HeartLab, OrthoHelix Surgical Designs, TGX Medical Systems) also point to MCP frequently taking a lead or co-lead role in companies within its Midwest healthtech geography.
Recent Activity
- August 2026: Portfolio company Elevation Spine received FDA clearance for its Saber-XA expandable interbody fusion system and Saber-C AVIA cervical fixation device.
- June 2026: Senior Associate Will Brune was promoted (internal team milestone).
- July 2025: Led Cooler Heads' oversubscribed $11M Series A for its FDA-cleared Amma portable scalp-cooling system for chemotherapy patients.
- July 2025: Portfolio company eBlu Solutions was acquired by Knipper Health (backed by Frazier Healthcare Partners), forming an "order to therapy initiation" platform — a full-cycle exit for MCP's Fund III cohort.
- 2024: Portfolio company RevLocal was acquired by Hibu, another MCPF II-era exit.
Fund status reads as actively deploying: MCPF IV is currently investing (Authenticx, Cooler Heads, iotaMotion), while MCPF III (Catalyst OrthoScience, Checkpoint Surgical, Elevation Spine, Olio Health, Redi.Health) continues to season and has already produced one exit (eBlu Solutions) in 2025.
Portfolio Highlights
Notable exits:
- eBlu Solutions → acquired by Knipper Health (2025)
- SPR Therapeutics → announced acquisition by Medtronic (2026, ~$650M)
- RevLocal → acquired by Hibu (2024)
- Cleveland HeartLab → acquired by Quest Diagnostics (2017)
- Cardinal Commerce → acquired by Visa (2016)
- Hemosphere → acquired by CryoLife (2012)
- OrthoHelix Surgical Designs → acquired by Tornier (2012)
- TGX Medical Systems → acquired by Integra LifeSciences (2017)
Active companies to watch: Cooler Heads (FDA-cleared scalp-cooling device, fresh $11M Series A), Authenticx (healthcare conversation-intelligence platform), OrthAlign (orthopedic precision alignment, widely adopted in joint replacement), 7SIGNAL (enterprise wireless network monitoring).
Co-founder Bill Trainor separately founded and manages Access Ventures, whose portfolio (including Upwork's IPO and exits to Nuance, IBM, and NCR) is a distinct fund from MCP but reflects the same team's broader technology investing track record prior to MCP's healthcare focus.
Team
- Bill Trainor, Co-founder — Leads the software/healthcare-IT practice. Previously Senior Vice President–Head of E-Commerce Investment Banking at McDonald Investments; active angel investor since 1997. Columbia University (Political Science). Also founded/manages Access Ventures.
- Wayne Wallace, Co-founder — Leads the medical device investing practice. Exits include Cleveland HeartLab (Quest Diagnostics), TGX Medical Systems (Integra LifeSciences), and OrthoHelix Surgical Designs (Tornier). Ohio State University (Business Administration/Finance). Immediate Past Chairman, Lakewood Catholic Academy board.
- Liz Todia Zambory, Principal — Handles deal sourcing, due diligence, portfolio support, and investor relations. University of Dayton (Entrepreneurship and Finance). Adjunct professor at the Weatherhead School of Management, Case Western Reserve University.
- Will Brune, Senior Associate — Manages due diligence and deal flow. Case Western Reserve University (M.S. Finance; B.S. Finance and Economics). Promoted to Senior Associate, June 2026.
Decision Process
A four-person team led by two co-founders who split the practice by domain (software/healthcare-IT vs. medical device) suggests a partnership-style decision process rather than a solo GP or large investment committee.
Founder Preferences
MCP's published criteria are explicit and unusually quantitative for a healthtech fund: $1M+ run-rate revenue, 50%+ gross margins, 5+ renewing/expanding reference customers, and capital needs under $10M. They also explicitly favor companies "located outside major tech hubs" — Ohio, Indiana, Michigan, and western Pennsylvania/New York — positioning MCP as a go-to growth-stage healthtech investor for Midwest and Rust Belt founders who may be overlooked by coastal funds.
Geographic Focus
Primarily Ohio, with an extended remit across Indiana, Michigan, and western Pennsylvania/New York. Headquartered at 1290 Bassett Rd, Suite #7, Westlake, OH 44145.